Objective: To investigate the effect of risperidone, quinthiapine and aripiprazole in the treatment of schizophrenia. Methods: 70 schizophrenic patients treated in Jiangxi Provincial Psychiatric Hospital from December 2016 to December 2017 were randomly divided into control group (n=35) and observation group (n=35). The control group was treated with risperidone and quetiapine. The observation group was treated with risperidone and aripiprazole. The therapeutic effect, mental symptoms, thyroxine level, recovery and social function of the two groups before and after treatment were compared and analyzed. Result: The therapeutic effect of the observation group was higher than that of the control group, and the mental symptoms, thyroxine level and the condition recovery were better in the observation group than in the control group, and the social function in the control group was worse than that in the observation group, the difference was statistically significant (P<0.05). Conclusion: On the basis of routine treatment, risperidone and aripiprazole have the best effect on schizophrenia, which is helpful to the patients' mental symptoms and rehabilitation, and has good clinical value.%目的:探讨分析对精神分裂症患者实施利培酮、喹硫平、阿立哌唑治疗的影响.方法:以2016年12月至2017年12月期间在江西省精神病院进行治疗的70例精神分裂症患者为本次研究的对象,将这些患者按照入院号随机的分为对照组和观察组,每组35例,对照组利培酮和喹硫平治疗,观察组给予利培酮和阿立哌唑治疗,在研究结束后对两组患者治疗前后的治疗效果、精神症状、甲状腺素水平、治疗后病情康复情况以及社会功能进行对比分析.结果:观察组治疗效果高于对照组,精神症状、甲状腺素水平以及病情康复情况均优于对照组,对照组社会功能比观察组差,差异具有统计学意义,P<0.05.结论:对精神分裂症患者以常规治疗为基础上,实施利培酮和阿立哌唑治疗的效果最好,对患者的精神症状、康复情况等都有一定的帮助,具有很好的临床价值.
展开▼
